China's AI unicorn cohort just crossed a major threshold — Zhipu AI and MiniMax both completed Hong Kong IPOs within 24 hours of each other in January 2026 — and the funding sources behind that cohort remain structurally different from their US counterparts even after going public.
Jan 8–9, 2026
Zhipu AI and MiniMax both list on HKEX
$80B
Zhipu AI's pre-IPO private valuation
$30B
Moonshot AI's target valuation, 3rd round since Dec 2025
$200M
Moonshot's ARR, April 2026 (from $100M in March)
In a genuinely significant first for the global AI industry, Zhipu AI listed on the Hong Kong Stock Exchange on January 8, 2026, with MiniMax following on January 9, 2026 — making them among the first frontier foundation-model companies anywhere in the world to complete a public listing, ahead of comparable US players like OpenAI or Anthropic, which remain private. Zhipu had carried a private valuation near $80 billion ahead of listing; post-IPO, its shares surged over 600% from the offering price in the following weeks, pushing its market capitalization to roughly $56 billion at that point in trading — a reminder that IPO pricing, private-round valuation, and subsequent public market capitalization can diverge substantially even for the same company within a matter of weeks, and that any single 'valuation' figure quoted for a Chinese AI company should be read alongside the specific date and context it was measured in.
MiniMax's debut was similarly dramatic: its shares doubled on the first day of trading and climbed to a market capitalization exceeding $33 billion in subsequent weeks, making it, by that measure, more valuable than Europe's own leading AI startup Mistral, which had been valued at $11 billion in a September 2025 private round. The near-simultaneous timing of the two listings — a single day apart — was widely read in market commentary as a coordinated signal from Chinese regulators and exchange authorities that Hong Kong is being positioned as the preferred public listing venue for the country's AI champions, ahead of both a mainland STAR Market listing and a US listing route.
Not every member of the AI Tiger cohort has gone public. Moonshot AI, maker of the Kimi assistant, remained private as of early 2026 and was in the process of raising its third funding round since December 2025 — a remarkably fast cadence — targeting a valuation near $30 billion, roughly seven times its valuation just six months earlier. The company's annual recurring revenue reportedly topped $200 million in April, having roughly doubled from $100 million at the start of March, an extraordinarily steep revenue growth curve even by frontier AI standards, and one that helps explain investor willingness to underwrite repeated valuation step-ups within months of each other rather than the more traditional 12–18 month gap between institutional rounds.
This creates a bifurcated picture within the same cohort: Zhipu AI and MiniMax have crossed into public markets with the disclosure obligations, liquidity, and scrutiny that entails, while Moonshot AI remains in a private fundraising cycle moving faster than almost any comparable company globally. A foreign investor evaluating exposure to this space in 2026 needs to track these as three distinct situations with three distinct liquidity profiles and diligence requirements, not as a single undifferentiated 'Chinese AI' category.
China's Leading AI Companies — Status and Valuation (Early 2026)
Zhipu AI and MiniMax figures reflect reported HKEX listing and subsequent trading data; Moonshot AI figure reflects its reported private fundraising target as of early 2026. Public market capitalizations move continuously; treat these as a snapshot, not a current quote.
This cohort's largest historical rounds routinely included a mix of strategic corporate investors (Alibaba, Tencent, and Xiaomi have all backed multiple foundation-model startups — Moonshot AI is itself Alibaba-backed), municipal guidance funds, and, in select cases, direct state fund participation, reflecting the sector's classification as a national strategic priority under the 14th and 15th Five-Year Plans. This creates a valuation dynamic that can look, from a distance, similar to the concentration seen in the US AI market around OpenAI and Anthropic — a small number of companies absorbing a disproportionate share of sector capital — but the underlying capital structure is different: US concentration is driven by scarcity of proven technical teams and compute access in a purely private capital market, while Chinese concentration is amplified by state industrial policy actively identifying and channeling capital toward a specific shortlist of "national champion" candidates, several of which have now been fast-tracked to a public listing as a matter of apparent policy preference.
Baichuan and 01.AI — both founded by well-known, technically credible figures from China's earlier internet generation (Baichuan by former Sogou CEO Wang Xiaochuan, 01.AI by AI researcher and former Google China head Kai-Fu Lee) — were widely grouped alongside Zhipu, Moonshot, and MiniMax in early "AI Tiger" cohort coverage, but have not kept pace with the same valuation trajectory or public-listing momentum as of early 2026. Their relative position illustrates a useful diligence point: founder pedigree and early media grouping into a "tiger" cohort label are not reliable predictors of which companies actually secure the compute access, state backing, and revenue traction needed to sustain a leadership position over a multi-year window — the cohort has already stratified meaningfully within itself, and a foreign investor should evaluate each company's current-state fundamentals independently rather than assuming cohort membership implies comparable trajectory.
Behind the valuation figures, the more decisive competitive variable in this sector — discussed at greater length in a related fact on AI funding concentration — is access to advanced compute, which has become entangled with US export-control policy and, at times, Chinese regulators' own domestic security preferences regarding foreign chips. A secondary but related constraint is talent: the pool of researchers with genuine frontier-model training experience is small globally, and Chinese foundation-model companies compete for this talent not only against each other but against well-funded US labs offering compensation packages that Chinese companies, even at $30–80 billion valuations, do not always match on a pure cash basis — meaning equity upside tied to a plausible path to an IPO (now demonstrated concretely by Zhipu and MiniMax) has become a genuinely important recruiting and retention tool in its own right, not just a financing mechanism.
What This Means For Foreign Investors
Treat Zhipu AI, MiniMax, and Moonshot AI as three separate diligence cases with three different structures (newly public with disclosure obligations, newly public with a different capital history, and privately racing through step-up rounds), and for any of them, weight your analysis of the cap table's strategic and state-linked investors as heavily as you weight the underlying technology — in this cohort, who else is at the table has historically shaped access to compute, regulatory approval, and even IPO sequencing as much as product execution has. Do not assume every company grouped into the "AI Tiger" media label commands comparable capital access — Baichuan and 01.AI's slower trajectory shows the cohort has already stratified.
HKEX listing coverage of Zhipu AI (Jan 8, 2026) and MiniMax (Jan 9, 2026) per TrendingTopics.eu and CNBC reporting; Moonshot AI valuation and revenue figures (Jan–Apr 2026) per TechJack Solutions / "The Nvidia Patterns" and CNBC coverage of Moonshot AI's fundraising; Mistral's $11B September 2025 valuation as reported comparative benchmark.
ZINVEO does not decide. It exposes structural asymmetry. Final decision remains
with the Investment Committee.
Search our coverage, or request direct access to ZINVEO's structural risk engine.